share_log

Needham Maintains Buy on Nurix Therapeutics, Maintains $31 Price Target

Needham Maintains Buy on Nurix Therapeutics, Maintains $31 Price Target

Needham維持對Nurix Therapeutics的買入,維持31美元的目標股價
Benzinga ·  04/02 09:20

Needham analyst Gil Blum maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and maintains $31 price target.

Needham分析師吉爾·布魯姆維持Nurix Therapeutics(納斯達克股票代碼:NRIX)的買入並維持31美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論